Abstract
Two different approaches, namely the electron conformational and genetic algorithm methods (EC-GA), were combined to identify a pharmacophore group and to predict the antagonist activity of 1,4-dihydropyridines (known calcium channel antagonists) from molecular structure descriptors. To identify the pharmacophore, electron conformational matrices of congruity (ECMC)—which include atomic charges as diagonal elements and bond orders and interatomic distances as off-diagonal elements—were arranged for all compounds. The ECMC of the compound with the highest activity was chosen as a template and compared with the ECMCs of other compounds within given tolerances to reveal the electron conformational submatrix of activity (ECSA) that refers to the pharmacophore. The genetic algorithm was employed to search for the best subset of parameter combinations that contributes the most to activity. Applying the model with the optimum 10 parameters to training (50 compounds) and test (22 compounds) sets gave satisfactory results (\( R_{training}^2 \)= 0.848, \( R_{test}^2 \)= 0.904, with a cross-validated q 2 = 0.780).
Similar content being viewed by others
References
Itai A, Tomioka N, Kato K (1995) In: Fujita T (ed) QSAR and drug design: new developments and applications. Elsevier, Amsterdam
Thomas G (2003) Fundamentals of medicinal chemistry. Wiley-Blackwell, Weinheim
Şafak C, Şimşek R (2006) Fused 1,4-dihydropyridines as potential calcium modulatory compounds. Mini Rev Med Chem 6:747–755
Fossheim R (1986) Crystal structure of the dihydropyridine Ca2+ antagonist felodipine. Dihydropyridine binding prerequisites assessed from crystallographic data. J Med Chem 29:305–307
Triggle DJ, Langs DA, Janis RA (1989) Ca2+ channel ligands: structure-function relationships of the 1,4-dihydropyridines. Med Res Rev 9:123–180
Jiang JL, Li AH, Jang SY, Chang L, Melman N, Moro S, Ji X, Lobkovsky EB, Clardy JC, Jacobson KA (1999) Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl-1,4-dihydropyridines as selective A3 adenosine receptor antagonists. J Med Chem 42:3055–3065
Rhee AM, Jiang JL, Melman N, Olah ME, Stiles GL, Jacobson KA (1996) Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors. J Med Chem 39:2980–2989
Triggle DJ (2003) 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol 23:293–303
Kahraman P, Turkay M (2007) Classification of 1,4-dihydropyridine calcium channel antagonists using the hyperbox approach. Ind Eng Chem Res 46:4921–4929
Mohajeri A, Hemmateenejad B, Mehdipour A, Miri R (2008) Modeling calcium channel antagonistic activity of dihydropyridine derivatives using QTMS indices analyzed by GA-PLS and PC-GA-PLS. J Mol Graph Model 26:1057–1065
Yao X, Liu H, Zhang R, Liu M, Hu Z, Panaye A, Doucet JP, Fan B (2005) QSAR and classification study of 1,4-dihydropyridine calcium channel antagonists based on least squares support vector machines. Mol Pharm 2:348–356
Takahata Y, Costa MCA, Gaudio AC (2003) Comparison between neural networks (NN) and principal component analysis (PCA): structure activity relationships of 1,4-dihydropyridine calcium channel antagonists (nifedipine analogues). J Chem Inf Comput Sci 43:540–544
Schleifer KJ, Tot E (2002) CoMFA, CoMSIA and GRID/GOLPE studies on calcium entry blocking 1,4-dihydropryridines. Quant Struct Act Relat 21:239–248
Safarpour MA, Hemmateenejad B, Miri R, Jamali M (2003) Quantum chemical-QSAR study of some newly synthesized 1,4-dihydropyridine calcium channel blockers. QSAR Comb Sci 22:997–1005
Niculescu SP (2003) Artificial neural networks and genetic algorithms in QSAR. J Mol Struct THEOCHEM 622:71–83
Cronin MTD, Schultz TW (2003) Pitfalls in quantitative structure–activity relationships (QSARs) for predicting toxicity. J Mol Struct THEOCHEM 622:39–52
Schultz TW, Cronin MTD (2003) Essential and desirable characteristics of ecotoxicity QSARs. Environ Toxicology Chem 22:599–607
Kubinyi H, Folkers G, Martin YC (eds) (1998) 3D QSAR in drug design: recent advances. Kluwer, Dordrecht
Hopfinger AJ, Wang S, Tokarski JS, Jin B, Albuquerque M, Madhav PJ, Duraiswami C (1997) Construction of 3D-QSAR models using the 4D-QSAR analysis formalism. J Am Chem Soc 119:10509–10524
Becker OM, Levy Y, Ravitz O (2000) Conformation spaces, and bioactivity. J Phys Chem B 104:2123–2135
Langer T, Hoffmann RD (eds) (2006) Pharmacophores and pharmacophore searches. Wiley-VCH, Weinheim
Guner OF (2002) History and evolution of the pharmacophore concept in computer-aided drug design. Curr Top Med Chem 2:1321–1332
Dimoglu AS, Vlad PF, Shvets NM, Coltsa MN, Guzel Y, Saracoglu M, Saripinar E, Patat S (1995) Electronic-topological investigations of the relationships between chemical structure and ambergris odor. New J Chem 19:1217–1226
Saripinar E, Guzel Y, Patat S, Yildirim I, Akcamur Y, Dimoglo A (1996) Electron-topological investigation of the structure–antitubercular activity relationship of thiosemicarbazone derivatives. Arzneim Forsch (Drug Res) 46:824–828
Guzel Y, Saripinar E, Yildirim I (1997) Electron-toplogical (ET) investigation of structure–antagonist activity of a series of dibenzo[a,d]cycloalkenimines. J Mol Struct THEOCHEM 418:83–91
Rosines E, Bersuker IB, Boggs JE (2001) Pharmacophore identification and bioactivity prediction for group I metabotropic glutamate receptor agonists by the electron-conformational QSAR method. Quant Struct Act Relat 20:327–333
Makkouk Al H, Bersuker IB, Boggs JE (2004) Quantitative drug activity prediction for inhibitors of human breast carcinoma. Int J Pharm Med 18:81–89
Marenich AV, Yong PH, Bersuker IB, Boggs JE (2008) Quantitative antidiabetic activity prediction for the class of guanidino- and aminoguanidinopropionic acid analogs based on electron-conformational studies. J Chem Inf Model 48:556–568
Bersuker IB, Bahceci S, Boggs JE, Pearlman RS (1999) A novel electron-conformational approach to molecular modeling for QSAR by identification of pharmacophore and anti-pharmacophore shielding. SAR QSAR Environ Res 10:157–173
Bersuker IB (2008) QSAR without arbitrary descriptors: the electron-conformational method. J Comput Aided Mol Des 22:423–430
Eriksson L, Andersson PL, Johansson E, Tysklind M (2006) Megavariate analysis of environmental QSAR data. Part I. A basic framework founded on principal component analysis (PCA), partial least squares (PLS), and statistical molecular design (SMD). Mol Divers 10:169–186
Dudek AZ, Arodz T, Galvez J (2006) Computational methods in developing quantitative structure–activity relationships (QSAR): a review. Comb Chem High Throughput Screening 9:213–228
Holland JH (1975) Adaptation in artificial and natural systems. University of Michigan, Ann Arbor
Terfloth L, Gasteiger J (2001) Neural networks and genetic algorithms in drug design. DDT 6:102–108
Verma A, Llora X, Venkataraman S, Goldberg DE, Campbell RH (2010) Scaling eCGA model building via data-ıntensive computing. In: WCCI 2010 IEEE World Congr on Computational Intelligence, Barcelona, Spain, 18–23 July 2010
Jones G (2010) GAPE: an improved genetic algorithm for pharmacophore elucidation. J Chem Inf Model 50:2001–2018
Reddy AS, Kumar S, Garg R (2010) Hybrid-genetic algorithm based descriptor optimization and QSAR models for predicting the biological activity of tipranavir analogs for HIV protease inhibition. J Mol Graph Model 28:852–862
Mercader AG, Duchowicz PR, Fernandez FM, Castro EA (2010) Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines. J Chem Inf Model 50:1542–1548
Guha R, Jurs PC (2005) Interpreting computational neural network QSAR models: a measure of descriptor importance. J Chem Inf Model 45:800–806
Sarıpınar E, Geçen N, Sahin K, Yanmaz E (2010) Pharmacophore identification and bioactivity prediction for triaminotriazine derivatives by electron conformational-genetic algorithm QSAR method. Eur J Med Chem 45:4157–4168
Sahin K, Sarıpınar E, Yanmaz E, Geçen N (2011) Quantitative bioactivity prediction and pharmacophore identification for benzotriazine derivatives using the electron conformational-genetic algorithm in QSAR. SAR and QSAR Environ Res. doi:10.1080/1062936X.2010.548341
Yanmaz E, Sarıpınar E, Sahin K, Geçen N, Çopur F (2011) 4D-QSAR analysis and pharmacophore modeling: Electron conformational-genetic algorithm approach for penicillins. Bioorg Med Chem. doi:10.1016/j.bmc.2011.02.035
Shafiee A, Miri R, Dehpour AR, Soleymani F (1996) Synthesis and calcium-channel antagonist activity of nifedipine analogues containing nitroimidazolyl substituent in guinea-pig ileal smooth muscle. Pharmaceut Sci 2:541–543
Miri R, Howlett SE, Knaus EE (1997) Synthesis and calcium channel modulating effects of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(thienyl)-5-pyridinecarboxylates. Arch Pharm Pharm Med Chem 330:290–294
Miri R, McEwen CA, Knaus EE (2000) Synthesis and calcium channel modulating effects of modified Hantzsch nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(pyridinyl or 2-trifluoromethylphenyl)-5-pyridinecarboxylates. Drug Dev Res 51:225–232
Miri R, Dehpour AR, Azimi M, Shafiee A (2001) Synthesis and smooth muscle calcium channel antagonist effect of alkyl, aminoalkyl-1,4-dihydro-2,6-dimethyl-4-nitroimidazole-3,5-pyridine dicarboxylates. J School Pharmacy Med Sci Univ Tehran 9:40–45
Miri R, Niknahad H, Vesal G, Shafiee A (2002) Synthesis and calcium channel antagonist activities of 3-nitrooxyalkyl, 5-alkyl-1,4-dihydro-2,6-dimethyl-4-(1-methyl-5-nitro-2-imidazolyl)-3,5-pyridinedicarboxylates. Il Farmaco 57:123–128
Wavefunction, Inc. (2006) SPARTAN, v.06. Wavefunction, Inc., Irvine
Bersuker IB (2003) Pharmacophore identification and quantitative bioactivity prediction using the electron-conformational method. Curr Pharm Des 9:1575–1606
Bersuker IB, Dimoglo AS (1991) The electron-topological approach to the QSAR problem. In: Lipkowitz KB, Boyd DB (eds) Reviews in computational chemistry, 2nd edn. Wiley, New York, pp 423–460
Bersuker IB, Bahceci S, Boggs JE, Pearlman RS (1999) An electron-conformational method of identification of pharmacophore and anti-pharmacophore shielding: application to rice blast activity. J Comput Aided Mol Des 13:419–434
Dimoglo AS, Shvets NM, Tetko IV, Livingstone DJ (2001) Electronic-topological investigation of the structure–acetylcholinesterase inhibitor activity relationship in the series of n-benzylpiperidine derivatives. Quant Struct Act Relat 20:31–45
Pavlov T, Todorov M, Stoyanova G, Schmieder P, Aladjov H, Serafimova R, Mekenyan O (2007) Conformational coverage by a genetic algorithm: saturation of conformational space. J Chem Inf Model 47:851–863
Consonni V, Ballabio D, Todeschini R (2009) Comments on the definition of the Q2 parameter for QSAR validation. J Chem Inf Model 49:1669–1678
Damme SV, Bultınck P (2007) Software news and update a new computer program for QSAR-analysis: ARTE-QSAR. J Comput Chem 28:1924–1928
Schuurmann G, Ebert RU, Chen J, Wang B, Kuhne R (2008) External validation and prediction employing the predictive squared correlation coefficients test set activity mean vs training set activity mean. J Chem Inf Model 48:2140–2145
Topliss JG, Edwards RP (1979) Chance factors in studies of quantitative structure–activity relationships. J Med Chem 22:1238–1244
Parr RG, Szentpaly L, Liu S (1999) Electrophilicity index. J Am Chem Soc 121:1922–1924
Chattaraj PK, Maiti B (2001) Reactivity dynamics in atom–field interactions: a quantum fluid density functional study. J Phys Chem A 105:169–183
Vleeschouwer FD, Speybroeck VV, Waroquier M, Geerlings P, Proft FD (2007) Electrophilicity and nucleophilicity index for radicals. Org Lett 9:2721–2724
Cramer CJ, Famini G, Lowrey AH (1993) Use of calculated quantum chemical properties as surrogates for solvatochromic parameters in structure–activity relationships. Acc Chem Res 26:599–605
Oliferenko AA, Oliferenko PV, Huddleston JG, Rogers RD, Palyulin VA, Zefirov NS, Katritzky AR (2004) Theoretical scales of hydrogen bond acidity and basicity for application in QSAR/QSPR studies and drug design. Partitioning of aliphatic compounds. J Chem Inf Comput Sci 44:1042–1055
Patel DM, Patel NM (2009) QSAR analysis of aminoquinoline analogues as MCH1 receptor antagonist. J Sci Res 1:594–605
Livingstone D (1995) Data analysis for chemists. Oxford University Press, New York
Wold S (1978) Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 20:397–405
Cramer R, Patterson D, Bunce J (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967
Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130–4146
Yang GF, Huang X (2006) Development of quantitative structure–activity relationships and its application in rational drug design. Curr Pharm Des 12:4601–4611
Fox T, Kriegl JM (2006) Machine learning techniques for in silico modeling of drug metabolism. Curr Top Med Chem 6:1579–1591
Helma C, Kazius J (2006) Artificial intelligence and data mining for toxicity prediction. Curr Comput Aided Drug Des 2:123–133
Acknowledgement
This project was financially supported by the Scientific Technical Research Council of Turkey (TUBITAK, Grant No. 107T385) and the Research Fund of Erciyes University (BAP, Project Number: FBD-09-928). The authors are grateful to Mustafa Yıldırım, Fatih Çopur and Serkan Şahin for their valuable suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Geçen, N., Sarıpınar, E., Yanmaz, E. et al. Application of electron conformational–genetic algorithm approach to 1,4-dihydropyridines as calcium channel antagonists: pharmacophore identification and bioactivity prediction. J Mol Model 18, 65–82 (2012). https://doi.org/10.1007/s00894-011-1024-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-011-1024-5